Andrew Stolz
Physician · Keck School of Medicine of USC
Credentials: · · · ·
History
2024–Present
- 1981–1984
Gastroenterology
- 1978–1981
Internal Medicine
1974–1978
Research
Features and Outcomes of 899 Patients With Drug-Induced Liver Injury: The DILIN Prospective Study
Gastroenterology · 2015 · 708 citations
Hepatology · 2014 · 311 citations
Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network
Hepatology · 2014 · 296 citations
34 papers
25 papers
20 papers
20 papers
- JS
17 papers
15 papers
- PH
15 papers
14 papers
Grants
- 2008–2028
USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $5.2M · University of Southern California
- 2021–2026
National Institute of Diabetes and Digestive and Kidney Diseases · U01
PI · $1.4M · University of Southern California
- 2007–2013
Targeting DHT Catabolism by AKR1Cs for Prostrate Cancer Prevention and Treatment.
National Cancer Institute · R01
Contact PI · $1.2M · University of Southern California
- 1997–2010
USC Research Center for Liver Disease
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $2.3M · University of Southern California
Clinical trials
- 2004–2028
- 2004–2028